US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 6.700
  • +0.360+5.68%
Close May 14 16:00 ET
510.06MMarket Cap-3366P/E (TTM)

Travere Therapeutic Key Stats

Travere Therapeutic Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 6, 2024

Revenue(YoY)

41.37M

+33.95%
EPS(YoY)

-1.76

-38.58%

Buy

May 14, 2024

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 60.071M--
--2024/Q2-- / 53.431M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--
Aug 3, 20232023/Q259.697M / 53.604M--
May 4, 20232023/Q156.993M / 50.608M--
Feb 23, 20232022/Q455.868M / 53.020M--
Oct 27, 20222022/Q353.496M / 54.118M--
Aug 4, 20222022/Q254.167M / 49.580M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 60.071M--
--2024/Q2-- / 53.431M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--
Aug 3, 20232023/Q259.697M / 53.604M--
May 4, 20232023/Q156.993M / 50.608M--
Feb 23, 20232022/Q455.868M / 53.020M--
Oct 27, 20222022/Q353.496M / 54.118M--
Aug 4, 20222022/Q254.167M / 49.580M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 14, 2024

Buy

  • Buy

    63.64%
  • Hold

    36.36%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg